Table 2.
Factor | Category | % 5 year survival (95% CI) | Log rank χ2(df) | Log rank p value |
Extent of spread | Slight | 89.3 (78.7–94.7) | 15.00 (2) | 0.0006 |
Moderate | 76.9 (67.2–84.1) | |||
Extensive | 61.5 (48.7–72.0) | |||
Peritoneal involvement | Absent | 84.3 (69.5–92.3) | 29.53 (3) | <0.0001 |
Inflammatory | 88.4 (80.1–93.4) | |||
Present | 67.0 (52.6–78.0) | |||
With ulceration | 50.9 (35.3–64.6) | |||
Peritoneal involvement | Absent/inflammatory | 87.1 (80.2–91.7) | 21.73 (1) | <0.0001 |
Present±ulceration | 59.9 (49.4–68.6) | |||
Venous invasion | Not evident | 83.7 (76.2–89.0) | 16.05 (2) | 0.0003 |
Submucosal | 73.0 (49.4–87.0) | |||
Extramural | 61.6 (49.6–71.5) | |||
Venous invasion | Not evident | 83.7 (76.2–89.0) | 15.23 (1) | 0.0001 |
Submucosal and/or extramural | 64.1 (53.7–72.8) | |||
Margin involvement | Absent | 78.7 (72.3–83.7) | 7.62 (2) | 0.02 |
Inflammatory | 57.1 (35.8–73.6) | |||
Present | Longest survivor FU only 47 months | |||
Margin involvement | Absent | 78.7 (72.3–83.7) | 7.31 (1) | 0.007 |
Inflamed or present | 55.3 (35.8–73.6) | |||
Tumour perforation | Absent | 76.6 (70.5–81.7) | 9.27 (1) | 0.0023 |
Present | 46.8 (14.8–73.9) | |||
Adjacent organ involvement | Absent | 78.4 (72.1–83.4) | 7.08 (1) | 0.008 |
Present | 51.7 (29.9–69.7) |
FU, follow up.